Crosswinds Holdings Inc Stock Toronto S.E.
Equities
CA2276961018
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.36M 37.44M |
---|---|---|---|---|---|
Net income 2021 | -4M -5.47M | Net income 2022 | -2M -2.74M | EV / Sales 2021 | - |
Net cash position 2021 | 2.23 3.05 | Net cash position 2022 | 0.02 0.02 | EV / Sales 2022 | - |
P/E ratio 2021 |
-17.8
x | P/E ratio 2022 |
-9.17
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.21% |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+47.07% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |